TTop stories Read More Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipelineMarch 25, 2026 Pharma giant Merck is buying U.S. biotech firm Terns Pharmaceuticals for $6.7 billion to boost its oncology pipeline,…